TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Johannes G Ramaekers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.